Market News
Latest news from Stock markets.
Fujifilm: Diversified Exposure To AI Through Chips, Software, And Healthcare
FUJIFILM Holdings demonstrates robust valuation metrics, supported by stable earnings and a diversified business model. While debt exceeds cash, FUJIY's income statement and earnings revisions highlight consistent profitability and prudent financial management. Japanese yen depreciation reinforces FUJIY's forward outlook.
...keep reeding on seekingalpha.com
Plaintiffs' Evidence Will Be Heard in Cases Alleging J&J's Talc Products Caused Women's Ovarian Cancer, Announced Levin Papantonio Attorney Chris Tisi
PENSACOLA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- A U.S. District Court Special Master in the talc multidistrict litigation (MDL) against Johnson & Johnson (J&J) entered an Opinion, reaffirming that plaintiffs may present expert testimony supporting general causation to the jury.
...keep reeding on globenewswire.com
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
ALACHUA, Fla. and TAMPA, Fla.
...keep reeding on globenewswire.com
VGSH: Cash-Plus Carry With Rate-Cut Optionality
Vanguard Short-Term Treasury Index Fund ETF remains a HOLD for capital preservation and steady carry, with low volatility due to its 2-year effective duration. VGSH benefits from a minimal 0.03% expense ratio and monthly distributions, making it an attractive defensive allocation in fixed income portfolios. Fed rate cuts are unlikely before mid-year; VGSH could benefit from price appreciation if employment data deteriorates and the Fed eases policy in H2 2026.
...keep reeding on seekingalpha.com
Regis Resources Limited (RGRNF) Q2 2026 Earnings Call Transcript
Regis Resources Limited (RGRNF) Q2 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
This Could Be 1 of the Best Fintech Stock Buying Opportunities I've Seen in Years
This company is a leader in Latin America's financial services industry, with a massive customer base. The stock trades at a cheaper forward price-to-earnings ratio than the S&P 500.
...keep reeding on fool.com
Steppe Gold Announces Corporate Update, Strong Fourth Quarter Production
Ulaanbaatar, Mongolia--(Newsfile Corp. - January 21, 2026) - Steppe Gold Ltd. (TSX: STGO) (OTCQX: STPGF) (FSE: 2J9) ("Steppe Gold" or the "Company") is pleased to provide a corporate update.
...keep reeding on newsfilecorp.com
Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced the pricing of an upsized underwritten public offering of 7,900,677 shares of its common stock at a price to the public of $22.15 per share. Gross proceeds from the underwritten public offering before deducting underwriting discounts and commissions and estimated offering expenses are expected to be approximately $175.0 million. All of the shares of common stock are being offered by Corvus. In addition, Corvus has granted the underwriters of the offering a 30-day option to purchase up to an additional 1,185,101 shares of common stock at the public offering price, less underwriting discounts and commissions.
...keep reeding on globenewswire.com
Sizing Up Seven Hills Realty Trust
Seven Hills Realty Trust faces margin compression from Fed easing, prompting a dividend cut but still offers a 12.2% yield. SEVN's portfolio is pressured by 23% exposure to higher-risk office loans and a near 100% payout ratio, raising sustainability concerns. Interest rate floors on most loans should limit further NIM erosion if rates fall, but office delinquencies remain a significant risk.
...keep reeding on seekingalpha.com
Why ServisFirst Bancshares Stock Popped Today
ServisFirst is improving its margins as it expands its lending operations. Expense controls are helping to drive the bank's earnings higher.
...keep reeding on fool.com
Collegium Pharmaceutical: Buying The Projected Growth For 2026
Collegium Pharmaceutical demonstrates strong profitability, upgraded 2026 guidance, and a robust balance sheet, reinforcing my bullish outlook and conviction upgrade. COLL's growth is shifting from Xtampza ER to Jornay PM, which is expected to drive $190M–$200M in 2025 revenue and deeper ADHD market penetration. The pain portfolio remains a stable cash generator, with authorized generics providing a smart revenue stream and mitigating immediate generic erosion risks.
...keep reeding on seekingalpha.com
Natural Gas Spikes on Arctic Freeze as Oil Tightens from Venezuela Supply Issues
Venezuelan oil exports under a $2 billion U.S. deal remain slow and insufficient to ease global supply tightness, while U.S. natural gas prices surged over 40% due to Arctic cold.
...keep reeding on fxempire.com
XLSR: High Turnover, High Expense Ratio, And Mixed Returns
State Street® US Sector Rotation ETF is an actively managed ETF utilizing a proprietary model to rotate between sectors of the S&P 500. The lion's share of its net assets is allocated to ETFs, but it holds common stocks too. Despite its promising strategy, XLSR has significantly underperformed IVV since inception. Risk-adjusted returns over May 2019–December 2025 were not appealing either.
...keep reeding on seekingalpha.com
NPCT: Still Paying Out More Than It Earns
Nuveen Core Plus Impact Fund remains a sell due to persistent NAV erosion and unsustainable dividend coverage. NPCT's high leverage (36%) and exposure to lower-rated securities increase risk, especially in a high-rate environment. The fund's dividend yield of 11.6% is not supported by net investment income, relying on realized gains and return of capital.
...keep reeding on seekingalpha.com
BioAge Announces Pricing of Upsized $115.0 Million Public Offering
EMERYVILLE, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (Nasdaq: BIOA) ("BioAge", “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced the pricing of its upsized underwritten public offering of 5,897,435 shares of its common stock at a price to the public of $19.50 per share. The gross proceeds from this offering are expected to be approximately $115.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by BioAge. The offering is expected to close on or about January 23, 2026, subject to the satisfaction of customary closing conditions. In addition, BioAge has granted the underwriters a 30-day option to purchase up to an additional 884,615 shares of common stock in connection with the offering. All of the shares of common stock are being offered by BioAge.
...keep reeding on globenewswire.com
2 Beaten-Down Stocks That Could Sink Even More in 2026
Sarepta Therapeutics' drug safety issues are overshadowing its innovative platform. Teladoc Health's financial results continue to worsen, and the stock looks unlikely to recover.
...keep reeding on fool.com
Elastic: AI Tailwinds And Undervalued
Elastic offers a narrow+ economic moat from high switching costs, robust cross-sell opportunities, and strong net expansion rates, supporting a bullish investment thesis. Financial flexibility is notable, with $1.39B cash, $0.57B debt, and a $500M share repurchase plan, enabling continued R&D and strategic acquisitions. Valuation models indicate Elastic is ~56.5% undervalued, with a fair value estimate of $108.8 and 16% revenue growth projected, justifying a stock position over options.
...keep reeding on seekingalpha.com
EWZ: Favorable Risk-Reward Even After A Strong 2025
iShares MSCI Brazil ETF's 2025 rally was driven by global flows, USD weakness, and carry—not by domestic growth or fiscal reform. Even after the re-rating, EWZ remains attractive versus developed markets, with high real carry anchoring the BRL and dividends supporting total returns. The 2026 upside depends less on Brazil “improving” and more on fiscal risk staying contained while global liquidity and political optionality do the work.
...keep reeding on seekingalpha.com
Earnings Estimates Keep Increasing: A Closer Look
The Q4 earnings season is off to a solid start, with the growth pace accelerating and most management teams painting a stable-to-positive outlook for their businesses.
...keep reeding on zacks.com
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Bitdeer Technologies Group Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTDR
New York, New York--(Newsfile Corp. - January 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitdeer Technologies Group (NASDAQ: BTDR) between June 6, 2024 and November 10, 2025, both dates inclusive (the "Class Period"), of the important February 2, 2026 lead plaintiff deadline. SO WHAT: If you purchased Bitdeer securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
Hillgrove Resources Limited (HLGVF) Q4 2025 Earnings Call Transcript
Hillgrove Resources Limited (HLGVF) Q4 2025 Earnings Call Transcript
...keep reeding on seekingalpha.com
Prediction: After Blasting 174% Higher Last Year, Rocket Lab Stock Will Return From Orbit in 2026. Here's Why
Rocket Lab is a leading player in the space economy. The company's revenue and margin profile are improving, and shareholders have been cheering the stock.
...keep reeding on fool.com
Crypto firm BitGo raises $212.8 million in US IPO
Crypto custody firm BitGo priced its U.S. initial public offering above its indicated range on Wednesday, raising $212.8 million and paving the way for the first stock market debut by a digital asset company in 2026.
...keep reeding on reuters.com
CenterPoint Energy continues to prepare for weekend winter weather and secures 600 additional frontline workers to support emergency response efforts as ERCOT issues Weather Watch and Texas Governor declares State of Emergency
Approximately 3,300 CenterPoint employees and contract workers supporting storm preparation and potential restoration efforts across Houston and parts of Southeast Texas State of Texas emergency response resources activated ahead of potential impacts ERCOT Weather Watch issued for Saturday to Tuesday; grid conditions expected to be normal Customers urged to have a plan and prepare now for freezing temperatures, high winds and potential ice accumulation HOUSTON, Jan. 21, 2026 /PRNewswire/ -- To support its customers and communities, and following several days of actively preparing for this weekend's forecasted severe winter weather system, CenterPoint Energy secured over 600 additional frontline workers for an expanded workforce of 3,300 workers to address the approaching winter storm. Additionally, the company is standing up three staging sites Thursday at strategic locations across the northern portion of the Greater Houston area to pre-position resources to support potential restoration efforts.
...keep reeding on prnewswire.com
StoneCo Enters 2026 Cheap, With Credit Set To Drive The Next Leg Of Earnings
StoneCo is shifting from TPV-led growth to credit- and banking-driven earnings, with a maturing loan book and deposit funding supporting more durable profitability. The ADR already trades as if Brazil's high cost of capital is permanent, which limits downside as long as execution and asset quality remain stable. Any normalization in interest rates or improvement in funding costs has an outsized impact on pre-tax earnings and valuation, creating asymmetric upside into 2026.
...keep reeding on seekingalpha.com
Mitsubishi Electric Named to Clarivate Top 100 Global Innovators 2026
TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has been recognized as one of the Clarivate Top 100 Global Innovators 2026 by Clarivate Plc, a global information services company based in the United Kingdom. Mitsubishi Electric's achievements in the field of intellectual property (IP) continue to be highly recognized, as evidenced by being named a Global Innovator for the 14th time. The company was ranked in 17th place overall this year. The award,.
...keep reeding on businesswire.com
United Airlines Distinguishes Between Loyalty, Rewards Programs
United Airlines grew its loyalty revenue by promoting loyalty rather than rewards, an executive said Wednesday (Jan. 21) during the company's fourth quarter earnings call. The airline's loyalty revenue saw year-over-year increases of 10% for the fourth quarter and 9% for the full year of 2025, according to a Wednesday earnings release.
...keep reeding on pymnts.com
Northern Star Resources Limited (NESRF) Q2 2026 Earnings Call Transcript
Northern Star Resources Limited (NESRF) Q2 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
You Need To Watch Microsoft and Amazon Before Investing in PBW ETF
Investors in Invesco WilderHill Clean Energy ETF (NYSEARCA:PBW) have watched shares climb 74% over the past year, rising from around $20 to $35.
...keep reeding on 247wallst.com
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Wealthfront
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Wealthfront To Contact Him Directly To Discuss Their Options If you suffered significant losses in Wealthfront stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 21, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Wealthfront Corporation ("Wealthfront" or the "Company") (NASDAQ: WLTH).
...keep reeding on newsfilecorp.com
Oil edges up after Trump steps backs from tariff threats over Greenland
Oil prices edged up on Thursday after the U.S. president stepped back from threats to impose tariffs in his effort to seize Greenland, reducing the risk of a U.S.–Europe trade war and supporting the global economy and oil demand.
...keep reeding on reuters.com
Why AMD Stock Jumped Today
AI-fueled demand is propelling AMD's chip sales. The semiconductor leader may have already sold out of server CPUs for the year.
...keep reeding on fool.com
BitGo Holdings Announces Pricing of Initial Public Offering
NEW YORK--(BUSINESS WIRE)--BitGo Holdings, Inc. (“BitGo”), the digital asset infrastructure company, announced today the pricing of its initial public offering of an aggregate of 11,821,595 shares of Class A common stock at a price to the public of $18.00 per share. The offering consists of 11,026,365 shares of Class A common stock being offered by BitGo and 795,230 shares of Class A common stock being offered by certain existing stockholders of BitGo. BitGo will not receive any proceeds from t.
...keep reeding on businesswire.com
StubHub Deadline: STUB Investors Have Opportunity to Lead StubHub Holdings, Inc. Securities Lawsuit
NEW YORK, Jan. 21, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of StubHub Holdings, Inc. (NYSE: STUB) pursuant and/or traceable to the Registration Statement issued in connection with StubHub's September 2025 initial public offering (the "IPO"), of the important January 23, 2026 lead plaintiff deadline. So what: If you purchased StubHub common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
Alvotech: Why FDA Delays Don't Break The Bull Case
Alvotech remains my favorite in the biosimilars market, which is expected to reach $151.6 billion by 2033. It already has five approved drugs, including biosimilars of AbbVie's Humira, Johnson & Johnson's Stelara/Simponi, and Eylea. Even though it received three CRLs in Q4, Alvotech expects its revenue to be between $650 million and $700 million in 2026, up 37.2% from 2024.
...keep reeding on seekingalpha.com
Is This Dividend King Stock a Buy After a Major Development?
Johnson & Johnson signed a deal to avoid tariffs. Although it faces other threats, it can overcome them.
...keep reeding on fool.com
3 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade
Nvidia remains well-positioned to be an artificial intelligence (AI) infrastructure leader. Alphabet's vertical integration sets it up to be a big AI winner.
...keep reeding on fool.com
Australia's Finance Sector Union slams ANZ over job cuts at Suncorp Bank divisions
Australia's Finance Sector Union condemned ANZ Group's decision to cut jobs across multiple Suncorp Bank divisions on Thursday, saying the layoffs contradict the commitments it made to workers when the sale was approved.
...keep reeding on reuters.com
NVE Corporation (NVEC) Q3 2026 Earnings Call Transcript
NVE Corporation (NVEC) Q3 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
BitGo Holdings prices US IPO at $18, Bloomberg News reports
BitGo Holdings has priced its initial public offering at $18 per share, above the marketed range, Bloomberg News reported on Wednesday, citing people familiar with the matter.
...keep reeding on reuters.com
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SLM Corporation
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in SLM to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in SLM between July 25, 2025 and August 14, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 21, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against SLM Corporation ("SLM" or the "Company") (NASDAQ: SLM) and reminds investors of the February 17, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on newsfilecorp.com
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses in Rezolute to Contact Him Directly to Discuss Their Options If you suffered significant losses in Rezolute stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 21, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rezolute, Inc. ("Rezolute" or the "Company") (NASDAQ: RZLT).
...keep reeding on newsfilecorp.com
PKW: Don't Miss The Growth From This Value-Oriented Fund
Invesco BuyBack Achievers ETF earns a Buy rating for its strong track record and unique buyback-focused strategy. PKW offers diversification across all 11 sectors, with notable weights in financials, consumer cyclicals, and health care, and a mid-cap tilt. Despite value-like metrics—forward PE of 12.83 and price-to-book of 2.25—PKW's returns have closely matched the S&P 500 over the past decade.
...keep reeding on seekingalpha.com
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options If you suffered significant losses in Beta Bionics stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 21, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aquestive Therapeutics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX).
...keep reeding on newsfilecorp.com
FFIV Investors Have Opportunity to Lead F5, Inc. Securities Fraud Lawsuit
NEW YORK, Jan. 21, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of F5, Inc. (NASDAQ: FFIV) between October 28, 2024 and October 27, 2025, both dates inclusive (the "Class Period"), of the important February 17, 2026 lead plaintiff deadline. So What: If you purchased F5 securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Integer Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - ITGR
NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integer Holdings Corporation (NYSE: ITGR) between July 25, 2024 and October 22, 2025, both dates inclusive (the “Class Period”), of the important February 9, 2026 lead plaintiff deadline.
...keep reeding on globenewswire.com
Accenture: I'm Starting A Position (Technical Analysis)
Accenture presents a bullish technical setup, trading above its 30-week EMA with upward-sloping momentum and strong volume accumulation. Despite deteriorating earnings revisions and weak growth, ACN's profitability remains outstanding, and institutional buying signals perceived undervaluation. Momentum has shifted positive, with the PPO entering bullish territory, historically preceding significant rallies for ACN.
...keep reeding on seekingalpha.com
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered in Vistagen to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Vistagen between April 1, 2024 and December 16, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 21, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Vistagen Therapeutics, Inc. ("Vistagen" or the "Company") (NASDAQ: VTGN) and reminds investors of the March 16, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on newsfilecorp.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages SLM Corporation a/k/a Sallie Mae Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLM
New York, New York--(Newsfile Corp. - January 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds persons who invested in securities of SLM Corporation a/k/a Sallie Mae (NASDAQ: SLM) between July 25, 2025 and August 14, 2025, both dates inclusive (the "Class Period"), of the important February 17, 2026 lead plaintiff deadline. SO WHAT: If you purchased SLM securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
GDX vs. GLDM: Gold Miners With Leverage or Direct Gold Price Exposure
GDX tracks gold mining stocks with higher volatility and deeper drawdowns, while GLDM is a lower-risk, physically backed gold bullion ETF GLDM charges a much lower expense ratio than GDX, making it more cost-effective for gold exposure Both funds are highly liquid with similar assets under management, but their underlying portfolios and risk profiles appeal to different investor goals CEO says this is worth 18 Nvidias. Will this make the world's first trillionaire?
...keep reeding on fool.com
This Is One of the Best Nuclear Stocks to Hold for the Next 10 Years
Constellation operates the largest fleet of nuclear power plants. The company is also the largest producer of electricity in the U.S. CEO says this is worth 18 Nvidias.
...keep reeding on fool.com